dpp-4 inhibitor with glp-1 receptor agonist combination not recommended ada inhibitors for type 2 diabetes management Drug mechanism of action of

Statistical significance was assessed using two-tailed unpaired t-tests with false discovery rate (FDR) correction using the two-stage step-up method of Benjamini, Krieger and Yekutieli (Q = 1%)

At 4% hematocrit, PS exposure was 10-times higher in Ringer than in cRPMI, however the difference was not significant either

Current evidence underscores the necessity of further scientific assessment, more precise regulatory definitions, and robust banned-substance detection strategies to ensure safe use among athletes, tactical professionals, and the general public

10.1007/s40292-020-00364-3 134 MazurekR.TharakanS.MavropoulosS